A Double Blind, Double Dummy, Randomized, Placebo-Controlled, 4 Period Cross-Over Study To Examine The Effect Of PF-06372865 On Evoked Pain Endpoints In Healthy Volunteers Using Pregabalin As A Positive Control
Phase of Trial: Phase I
Latest Information Update: 18 Dec 2014
At a glance
- Drugs PF 6372865 (Primary) ; Pregabalin
- Indications Pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 15 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
- 03 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.